FluoRok develops safer and more sustainable fluorochemicals, including lithium hexafluorophosphate for lithium-ion batteries, using innovative technology that bypasses hazardous processes.

OQC provides quantum compute-as-a-service (QCaaS), developing and deploying enterprise-ready quantum computing platforms for global business applications.

Sitryx Therapeutics is a biopharmaceutical company that develops disease-modifying therapeutics for chronic autoimmune and inflammatory diseases by targeting and regulating cell metabolism.

AlveoGene is a UK-based biotech company that develops inhaled gene therapies for rare respiratory diseases, with an initial focus on alpha-1 antitrypsin deficiency disease.